Emphasizes that the United States aims to provide access to prescription drugs at lower costs for US patients and taxpayers, ...

In signing an executive order aimed at reducing U.S. drug prices, President Donald Trump said some prices would be cut in ...

For the first time in history, Medicare has the power to negotiate the price it pays for some of the costliest and most-used ...

To be clear, that concern was well-founded: High drug prices are one reason the U.S. has become a global leader in medical innovation. Some of the most important advancements in the field — from ...

The Centers for Medicare & Medicaid Services May 12 released draft guidance for the third round of negotiations for the Medicare Drug Price Negotiation Program. The guidance includes policies ...

Under the Medicare Drug Price Negotiation Program, the HHS secretary negotiates directly with manufacturers on the prices ...

President Donald Trump signed an Executive Order (EO) titled “Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients” aimed ...

The Trump administration is already gearing up for another round of Medicare drug price negotiations, while OpenAI launched a ...

CMS draft expands drug price talks to include Medicare Part B drugs and outlines steps for future renegotiations; public ...

President Trump signed an executive order Monday that will attempt to bring the down the cost of some drugs in the United States — but why are drugs so high to begin with?

Medicare is expanding its drug price negotiation program to include 15 more medications, including popular drugs like Ozempic.

The executive order would require other countries to pay more for medications so that Americans could pay less. But experts ...